SunWay Biotech Presentation of 2021 BIO Asia-Taiwan (Online)
We sincerely invite you to join us in the SunWay Biotech Presentation of BIO Asia-Taiwan. Please register for Free Admission to On-demand Company Presentations of BIO Asia-Taiwan during July 21-25. After registration, please click Session and then type cp31 or SunWay to join our Company Presentation and know more about our service.
Register Now: https://bit.ly/3xFl57D
Congratulations! The innovation of Professor Tzu-Ming Pan and SunWay Biotech is awarded “Advanced National Innovation Award” on 1 Dec 2020!
We, Innovators The innovation of Professor Tzu-Ming Pan and SunWay Biotech “The Red Yeast Rice- Improvement of Memory and Learning Abilities of Alzheimer’s Patients” was awarded the National Innovation Award in 2008. With the continuous innovation, specific research, and development process for promotion worldwide, this application has been twice awarded the “Advanced National Innovation Award” on 1 Dec 2020! Advanced National Innovation Award Advanced National Innovation Award Advanced National Innovation Award Advanced National Innovation Award
Dr. Tzu-Ming Pan, head of technology of SunWay Biotech, was invited as speaker in 4th World Congress and Expo on Traditional and Alternative Medicine.
During 14-16 March 2021, 4th World Congress and Expo on Traditional and Alternative Medicine is organized in collaboration with Taipei Chinese Medical Association, Meridian World Health Organization Alliance (MWHOA), Chang Gung University, Tzu Chi University, I Shou University, and China Medical University. The Congress focused on the theme “World Health for everyone with local Wisdom and Resources,” with the domestic well-known speakers and international scholars were invited to publish the research of traditional and alternative medical therapies for global health issues through this online conference. The Head of Technology of SunWay Biotech, Dr. Tzu-Ming Pan, was invited as a speaker by Taipei Chinese Medical Association and Global Scientific Guild to announce at the conference that heart health supplement plays an important role for global health. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death globally. WHO says that about 17.9 million people worldwide died from CVDs in 2016 alone, representing 31 percent of all global deaths. Moreover, amid the COVID-19 crisis, the global market for Heart Healthy Ingredients estimated at US$16.6 Billion in the year 2020, is projected to reach a revised size of US$24.8 Billion by 2027, growing at a of 5.9% over the analysis period 2020-2027. Red yeast rice, as a dietary supplement ingredient for heart health, is prized for its ability to lower cholesterol […]
A CL member asked about a newer type of red yeast rice known as ANKASCIN 568-R Plus. ConsumerLab added information about it to its Red Yeast Rice Review. Ankascin 568-R Plus A very different type of red yeast rice product on the market is Ankascin 568-R Plus (Sunway Biotech Co., Ltd., Taiwan), which contains an extract of red yeast rice focusing on two compounds, ankaflavin and monascin, as opposed to the lovastatin compounds normally in red yeast rice products. It is a certified health food in Taiwan for regulating lipid function and to assist in regulating blood glucose function. It was accepted by the U.S. FDA as a new dietary ingredient in 2018 (which does not mean that it is effective, but that the FDA has not expressed safety concerns). An 8-week, placebo-controlled (but not double-blinded) study in Taiwan among 40 people with metabolic syndrome found no negative effects of Ankascin 568-Plus (500 mg daily) on liver, kidney, or thyroid function, nor any indication of muscle breakdown. There was no significant decrease in fasting blood glucose or triglyceride levels compared to placebo, but there was a 19% decrease in LDL cholesterol versus a 1.9% decrease with placebo. Although funding of the study was not disclosed, one of the study authors is employed by Sunway Biotch (Liu, J Food Drug Analysis 2018). It […]